1. Animal modelling of human polymorphic drug oxidation-the metabolism of debrisoquine and phenacetin in rat inbred strains.;Al-Dabbagh;J Pharm Pharmacol,1981
2. CYP2D6 mRNA expression in circulating peripheral blood mononuclear cells correlates with in vivo debrisoquine hydroxylase activity in extensive metabolizers.;Carcillo;Res Commun Mol Pathol Pharmacol,1996
3. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.;Chow;Drug Metab Dispos,1999
4. The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspects
5. 1- and 3-Hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans.;Eiermann;Drug Metab Dispos,1998